Gennadios Aristippos

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$8.53M

Insider Activity of Gennadios Aristippos

According to the SEC Form 4 filings, Gennadios Aristippos, being in a position of

  1. Group Pres. Pharma & Consumer at Catalent, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1518 shares for $90,100,
    over all time since 2015-04-01, has bought 0 shares, and sold 141087 shares for $8.53M.

The largest sale of all time was on 2019-11-25 and amounted to 90512 shares of Catalent, Inc. for $4.76M.

Biography of Gennadios Aristippos

No biography is available at this moment.

2024-08-02SaleCatalent, Inc.
CTLT
Group Pres. Pharma & Consumer
1,169
0.0006%
$59.55$69,614+0.44%
2024-07-29SaleCatalent, Inc.
CTLT
Group Pres. Pharma & Consumer
349
0.0002%
$58.70$20,486+1.37%
2023-08-24SaleCatalent, Inc.
CTLT
Group Pres. Pharma & Consumer
396
0.0002%
$44.49$17,618+22.22%
2023-08-01SaleCatalent, Inc.
CTLT
Group Pres. Pharma & Consumer
281
0.0002%
$47.59$13,373+7.67%
2022-08-24SaleCatalent, Inc.
CTLT
Group Pres. Pharma & Consumer
1,645
0.0009%
$103.04$169,501-53.08%
2022-07-26SaleCatalent, Inc.
CTLT
Group Pres. Pharma & Consumer
403
0.0002%
$106.90$43,081-52.83%
2021-08-27SaleCatalent, Inc.
CTLT
President Softgel & Oral Tech
2,262
0.0013%
$131.13$296,619-15.41%
2021-07-26SaleCatalent, Inc.
CTLT
President Softgel & Oral Tech
465
0.0003%
$113.05$52,568-1.66%
2021-01-04SaleCatalent, Inc.
CTLT
President Softgel & Oral Tech
220
<0.0001%
$52.21$11,486+12.08%
2020-12-21SaleCatalent, Inc.
CTLT
President Softgel & Oral Tech
17,598
0.0087%
$85.31$1.5M+11.03%
2020-06-25SaleCatalent, Inc.
CTLT
President Softgel & Oral Tech
16,650
0.0106%
$73.00$1.22M+39.88%
2019-11-25SaleCatalent, Inc.
CTLT
President Softgel & Oral Tech
90,512
0.0616%
$52.55$4.76M+36.16%
2019-03-21SaleCatalent, Inc.
CTLT
President, Softgel Tech.
6,784
0.0046%
$42.18$286,179+19.56%
2015-04-01SaleCatalent, Inc.
CTLT
See Remarks
2,353
0.0019%
$30.61$72,025-9.4%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.